Search Patents
-
Patent number: 8481085Abstract: The present invention relates to the use of cannabigerol (CBG) type compounds and derivatives thereof in the treatment of mood disorders.Type: GrantFiled: June 8, 2007Date of Patent: July 9, 2013Assignee: GW Pharma LimitedInventors: Richard Musty, Richard Deyo
-
Publication number: 20120225136Abstract: The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration.Type: ApplicationFiled: April 5, 2012Publication date: September 6, 2012Applicant: GW Pharma LimitedInventors: Brian Whittle, Daniela Parolaro
-
Patent number: 6730330Abstract: The invention relates to pharmaceutical formulations for use in the administration of medicaments, in particular lipophilic medicaments, via mucosal surfaces.Type: GrantFiled: April 5, 2001Date of Patent: May 4, 2004Assignee: GW Pharma LimitedInventors: Brian A. Whittle, Geoffrey W. Guy
-
Patent number: 8771760Abstract: The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.Type: GrantFiled: April 26, 2011Date of Patent: July 8, 2014Assignee: GW Pharma LimitedInventors: Geoffrey Guy, Philip Robson
-
Patent number: 10758514Abstract: The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.Type: GrantFiled: May 2, 2018Date of Patent: September 1, 2020Assignee: GW Pharma LimitedInventors: Wai Liu, Katherine Scott, Angus Dalgleish, Marnie Duncan, Colin Stott
-
Publication number: 20100119606Abstract: Processes for preparing extracts of natural products such as plant material, and for preparing purified extracts from crude extracts of natural products, by extraction with hot gas. Apparatus suitable for use in preparing extracts of natural products are also described.Type: ApplicationFiled: November 13, 2009Publication date: May 13, 2010Applicant: GW Pharma LimitedInventors: Brian Whittle, Geoffrey Guy, David Downs, David W. Pate
-
Patent number: 7968594Abstract: The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.Type: GrantFiled: April 27, 2005Date of Patent: June 28, 2011Assignee: GW Pharma LimitedInventors: Geoffrey Guy, Philip Robson
-
Patent number: 9034395Abstract: Processes for preparing extracts of natural products such as plant material, and for preparing purified extracts from crude extracts of natural products, by extraction with hot gas. Apparatus suitable for use in preparing extracts of natural products are also described.Type: GrantFiled: November 13, 2009Date of Patent: May 19, 2015Assignee: GW Pharma LimitedInventors: Brian Whittle, Geoffrey Guy, David Downs, David W. Pate
-
Publication number: 20140377382Abstract: The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise: i) a cannabinoid-containing fraction; and ii) a non-cannabinoid containing fraction.Type: ApplicationFiled: January 24, 2014Publication date: December 25, 2014Applicant: GW Pharma LimitedInventors: Geoffrey Guy, Bettina Platt
-
Publication number: 20140287067Abstract: The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).Type: ApplicationFiled: November 14, 2013Publication date: September 25, 2014Applicants: GW Pharma Limited, Otsuka Pharmaceutical Co., LimitedInventors: Guillermo Velasco Diez, Manuel Guzman Pastor, Mar Lorente, Sofia Torres, Fatima Rodriguez
-
Patent number: 8632825Abstract: The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumor, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).Type: GrantFiled: June 4, 2009Date of Patent: January 21, 2014Assignees: GW Pharma Limited, Otsuka Pharmaceutical Co., LimitedInventors: Guillermo Velasco Diez, Manuel Guzman Pastor, Mar Lorente, Sofia Torres, Fatima Rodriguez
-
Patent number: 7622140Abstract: Processes for preparing extracts of natural products such as plant material, and for preparing purified extracts from crude extracts of natural products, by extraction with hot gas. Apparatus suitable for use in preparing extracts of natural products are also described.Type: GrantFiled: May 7, 2002Date of Patent: November 24, 2009Assignee: GW Pharma LimitedInventors: Brian Whittle, Geoffrey Guy, David Downs, David Pate
-
Patent number: 8673368Abstract: The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise: i) a cannabinoid-containing fraction; and ii) a non-cannabinoid containing fraction.Type: GrantFiled: January 17, 2007Date of Patent: March 18, 2014Assignee: GW Pharma LimitedInventors: Geoffrey Guy, Bettina Platt
-
Patent number: 9205063Abstract: The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise: i) a cannabinoid-containing fraction; and ii) a non-cannabinoid containing fraction.Type: GrantFiled: January 24, 2014Date of Patent: December 8, 2015Assignee: GW Pharma LimitedInventors: Geoffrey Guy, Bettina Platt
-
Publication number: 20100239693Abstract: The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise: i) a cannabinoid-containing fraction; and ii) a non-cannabinoid containing fraction.Type: ApplicationFiled: January 17, 2007Publication date: September 23, 2010Applicant: GW Pharma LimitedInventors: Geoffrey Guy, Bettina Platt
-
Patent number: 6946150Abstract: The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.Type: GrantFiled: August 14, 2002Date of Patent: September 20, 2005Assignee: GW Pharma LimitedInventor: Brian Whittle
-
Patent number: 10807777Abstract: The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.Type: GrantFiled: December 3, 2019Date of Patent: October 20, 2020Assignee: GW Pharma LimitedInventor: Brian Anthony Whittle
-
Patent number: 8603515Abstract: The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.Type: GrantFiled: June 1, 2012Date of Patent: December 10, 2013Assignee: GW Pharma LimitedInventor: Brian Anthony Whittle
-
Publication number: 20030021752Abstract: The invention relates to pharmaceutical formulations for use in the administration of lipophilic medicaments via mucosal surfaces. In particular the invention provides pharmaceutical formulations for use in administration of a lipophilic medicament via a mucosal surface which upon hydration form an emulsion containing the lipophilic medicament which is capable of adhering to a mucosal surface and allowing controlled release of the medicament. The invention further provides pharmaceutical formulations which contain, as active ingredients, specific combinations of cannabinoids in pre-defined ratios.Type: ApplicationFiled: September 12, 2001Publication date: January 30, 2003Applicant: GW Pharma LimitedInventors: Brian A. Whittle, Geoffrey W. Guy
-
Patent number: 10179683Abstract: The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.Type: GrantFiled: April 14, 2015Date of Patent: January 15, 2019Assignee: GW Pharma LimitedInventor: Brian Anthony Whittle